Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma
NCT07916389Phase 2Not yet recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Nov 2026
- Primary completion
- Nov 2034
- Countries
- 1
01
Overview
A Phase 2 trial of alectinib, entrectinib in infant-type hemispheric glioma (IHG), sponsored by St. Jude Children's Research Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
alectinibentrectinib
03
Conditions
infant-type hemispheric glioma (IHG)
Beyond the preview
Go deeper on NCT07916389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916389.